CSF Glucose Concentrations in Infants with Febrile Convulsions and the Possible Effect of Acetaminophen

Indian Pediatrics

Volumn 40, Issue 12, 2003, Pages 1183-1186

  Mohammadi, Mahmoud ^a,c   Mohebbi, Mohammad R ^a   Naderi, Fariba ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

Acetaminophen; CSF glucose; Febrile seizure

Indexed keywords

GLUCOSE; PARACETAMOL;

AGE; ARTICLE; BODY TEMPERATURE; CEREBROSPINAL FLUID; CORRELATION COEFFICIENT; DISEASE DURATION; DRUG EFFECT; FEBRILE CONVULSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SEIZURE;

ACETAMINOPHEN; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOSE; HUMANS; INFANT; MALE; PROBABILITY; RETROSPECTIVE STUDIES; SEIZURES, FEBRILE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0347517874     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rutter N, Smales ORC. Calcium, magnesium and glucose levels in blood and CSF of children with febrile convulsions. Arch Dis Child 1976; 51: 141-143.
2. Wallace S. Investigation at presentation. In: Wallace S, editor. The Child with Febrile Seizures. London: Wright, 1988; P 70-80.
3. Kiviranta T, Airaksinen EM, Tuomisto L. The role of fever on cerebrospinal fluid glucose concentration of children with and without convulsions. Acta Pediatrica 1995; 84: 1276-1279.
4. Brayden RM, Headley RM. Ambulatory Pediatrics. In: hay WW, Hayward AR, Levin JM, editors. Current Pediatric Diagnosis and Treatment. Lebanon: Appleton & Lange, 1999; 622-694.
5. Fishman MA. Febrile seizures. In: McMillan JA, DeAngelis CD, Feigin DR, Warshaw JB, editors. Oski's Pediatric Principles and Practices. Philadedlphia: Lippincott William & Willkins, 1999; 1949-1951.
6. Sacks DB. Carbohydrates. In: Burtis CA, Ashwood ER, editors. Tietz Textbook of Clinical Chemistry. Philadelphia: W.B. Saunders, 1994; 960-967.
7. Fishman RA. The glucose transporter protein and glycopenic brain injury. N Engl J Med 1991; 325: 731-732.
8. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and develop-mental delay. N Engl J Med 1991; 325: 703-709.
9. Labadie EL. Cerebrospinal fluid alterations associated with central nervous system infections. In: Wood JH, Ed. Neurobiology of Cerebrospinal Fluid. New York and London: Plenum Press, 1982; 433-448.
10. Reimers JI. Interleukin-I beta induced trasient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus? Dan Med Bull 1998; 45: 157-180.
11. Dinarello CA. Biology of interleukin-1. FASEB J 1988; 2: 108-115.
12. Lange CH, Cooney R, Vary TC. Central interleukin-1 partially mediates endotoxin-induced changes in glucose metabolism. Am J Physiol 1996; 271: E309-316.